Early Treatment of Atrial Fibrillation for Stroke Prevention Trial "EAST"


Phase 4 Results N/A

Summary of Purpose

EAST prospectively tests the hypothesis that an early, structured rhythm control therapy based on antiarrhythmic drugs and catheter ablation can prevent atrial fibrillation (AF) related complications in patients with AF when compared to usual care. Patients will be randomized to early therapy or usual care. In the early therapy group, patients will receive either catheter ablation (usually by pulmonary vein...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 October 2016.

1 Feb 2011 1 Feb 2011 1 Jun 2019 1 Nov 2019 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


See All